How it works
How the Medicare GLP-1 Bridge works
What is the Medicare GLP-1 Bridge?
The Medicare GLP-1 Bridge is a CMS pilot program that gives eligible Medicare Part D beneficiaries a $50 monthly copay on GLP-1 medications prescribed for weight loss. It runs from July 1, 2026 through December 31, 2027. Historically Medicare did not cover drugs used only for weight loss; the Bridge is a temporary pathway that changes that for people who meet the criteria.
Who qualifies for the GLP-1 Bridge?
You generally need Medicare Part D plus a weight and health profile that meets the program's criteria. In broad terms that means a higher BMI, or a moderately high BMI combined with a qualifying weight-related condition such as prediabetes, a past heart attack or stroke, or symptomatic peripheral artery disease. If you already have a condition like type 2 diabetes, Medicare may cover a GLP-1 for you through a different, usually better path.
The exact rules are detailed, and only your doctor and Medicare can make the final call. The fastest way to get a plain answer for your situation is the free check on this site.
Not sure where you land? Run the 1-minute eligibility check →
Which drugs are covered?
The Bridge covers Wegovy, Zepbound (KwikPen), and Foundayo when they are prescribed for weight loss. These are the GLP-1 medications approved for chronic weight management.
It does not cover Ozempic or Mounjaro. Those drugs share the same active ingredients as Wegovy and Zepbound, but they are approved for type 2 diabetes, not weight loss, so they fall outside this program.
What is the step-by-step process?
The Bridge has one order-of-operations rule that trips people up: the pharmacy claim has to be denied before the paperwork can be filed. Here is the sequence.
- See your doctor. Ask to be evaluated for the Medicare GLP-1 Bridge and get a prescription for a covered drug.
- Take it to the pharmacy first — and expect a denial. The pharmacy submits the claim to Medicare and it comes back denied. This is required. That denial is what opens the Bridge pathway.
- Your doctor files the prior authorization referencing that denial. This is the request that actually unlocks the $50 copay.
- Once approved, you pay $50 a month at the pharmacy for a covered drug, at any dose.
What does it cost if you don't qualify?
If you don't qualify for the Bridge, GLP-1 weight-loss drugs generally run about $1,000 to $1,350 per month at list price without coverage. Manufacturer cash-pay programs and savings cards can bring that down, and prices change often. Your doctor or pharmacist can help you compare the current options for your situation.
How long does the program last?
The pilot runs from July 1, 2026 through December 31, 2027. It is a time-limited program, so the window to use it is now. Whether CMS extends, changes, or ends it after 2027 is not yet decided.
Frequently asked questions
Is this the same as Ozempic or Mounjaro coverage?
No. Ozempic and Mounjaro are approved for type 2 diabetes and are not part of the Bridge. The Bridge covers weight-loss drugs: Wegovy, Zepbound, and Foundayo.
Does this website decide if I'm eligible?
No. The check on this site is educational and gives you a plain, informational answer to bring to your doctor. Only your doctor and Medicare's program can determine eligibility.
Are my answers stored anywhere?
No. The eligibility check runs entirely in your browser. Your answers are never saved or sent to any server.
What if my pharmacy says the drug isn't covered?
That denial is a normal, required part of the Bridge process. Bring it to your doctor, who then files the prior authorization that references the denial.
Run a clinic and want to help patients through this?
See Bridge Check for Clinics